Related Experiment Video
Updated: Oct 27, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old
Robert H Pantell1, Kenneth B Roberts2, William G Adams3
1Department of Pediatrics, School of Medicine, University of California San Francisco, San Francisco, California Robert.Pantell@UCSF.edu.
Insights
This guideline provides evidence-based recommendations for evaluating and managing fever in well-appearing infants aged 8 to 60 days. It offers guidance on diagnostic testing and antimicrobial use to optimize infant care.
Area of Science:
- Pediatrics
- Infectious Disease Management
Background:
- Fever in infants 8 to 60 days old requires careful evaluation.
- Existing guidelines may not fully incorporate latest evidence or shared decision-making.
Purpose of the Study:
- To provide evidence-based guidelines for the evaluation and management of fever in well-appearing, term infants (8-60 days).
- To develop key action statements, including numbers needed to test and treat, and decision-making algorithms.
Main Methods:
- Commissioned evidence-based review by the Agency for Healthcare Research and Quality.
- Extensive literature review and analysis of supplemental data from peer-reviewed studies.
- Assessment of evidence quality and benefit-harm for 21 key action statements.
Main Results:
- Derived 21 key action statements with graded recommendations based on evidence quality and benefit-harm assessment.
- Developed "numbers needed to test" for diagnostic testing and "numbers needed to treat" for antimicrobial administration.
- Created three algorithms to guide management for specific infant age groups (8-21, 22-28, 29-60 days).
Conclusions:
- Recommendations emphasize incorporating parental values and preferences into shared decision-making.
- Guideline provides a framework for managing infant fever but allows for individualized care.
- Algorithms aim to standardize and optimize the evaluation and treatment of febrile infants.
Abstract:
This guideline addresses the evaluation and management of well-appearing, term infants, 8 to 60 days of age, with fever ≥38.0°C. Exclusions are noted. After a commissioned evidence-based review by the Agency for Healthcare Research and Quality, an additional extensive and ongoing review of the literature, and supplemental data from published, peer-reviewed studies provided by active investigators, 21 key action statements were derived. For each key action statement, the quality of evidence and benefit-harm relationship were assessed and graded to determine the strength of recommendations. When appropriate, parents' values and preferences should be incorporated as part of shared decision-making. For diagnostic testing, the committee has attempted to develop numbers needed to test, and for antimicrobial administration, the committee provided numbers needed to treat. Three algorithms summarize the recommendations for infants 8 to 21 days of age, 22 to 28 days of age, and 29 to 60 days of age. The recommendations in this guideline do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.
More Related Videos
Related Concept Videos
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Increased Body Temperature
Drug Dosing: Infants and Children
Patterns of Fever
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmacokinetics in Pediatric Patients: Drug Excretion

